168 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
11 Jun 24
Departure of Directors or Certain Officers
4:15pm
the U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA”), maintained for a select group of management or highly compensated … participation in, or benefits accrued under, any Company employee benefit plan or arrangement, which amounts shall be payable in accordance with the terms
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
15 May 24
Adaptimmune Reports Q1 2024 Financial and Business Updates
7:39am
in the three months ended March 31, 2024 increased in employee-related costs and additional costs associated with lease properties following
8-K
EX-10.1
bhau3jai1fck v7
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
8-K
4gx 9lxcuvj
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
S-8
higvz2kj
30 Nov 23
Registration of securities for employees
4:16pm
S-8
vwen2z rgevre29sy
30 Nov 23
Registration of securities for employees
4:16pm
S-8
EX-5.1
dukb2
30 Nov 23
Registration of securities for employees
4:16pm
S-8 POS
p9tl0d0 2pk731hr
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:54pm
S-8 POS
93qcrmzm4 xi1
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:48pm
8-K
9hxlfi3s5fwso ey
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.2
lmodgkkeu dl9
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
njhe8r6co 951xr7x7fm
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.3
a4ctxd4bse9xsexnk5m
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
6z8wa8 w2lzy83
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm